RMTI - Rockwell Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Rockwell Medical, Inc.

30142 Wixom Road
Wixom, MI 48393
United States
248-960-9009
http://www.rockwellmed.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees269

Key Executives

NameTitlePayExercisedYear Born
Mr. Stuart PaulPres, CEO & Director484.62kN/A1960
Mr. Angus W. SmithChief Financial Officer145kN/A1983
Dr. Ajay GuptaChief Scientific Officer & Member of Scientific Advisory Board566.41kN/A1958
Mr. Michael DeYoungVP of OperationsN/AN/AN/A
Mr. Paul E. McGarryVP, Corp. Controller & Principal Accounting OfficerN/AN/A1968
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rockwell Medical, Inc. operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. It is also developing an intravenous formulation of Triferic for use by hemodialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1994 and is based in Wixom, Michigan.

Corporate Governance

Rockwell Medical, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 10. The pillar scores are Audit: 10; Board: 4; Shareholder Rights: 4; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.